Determination of free catecholamines in urine by tandem affinity/ion-pair chromatography and flow injection analysis

David H. Thomas, Jay D. Taylor, Omar S. Barnaby, David S. Hage

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: A system was developed for the simultaneous measurement in urine of free catecholamines (i.e., dopamine, norepinephrine, epinephrine) and creatinine (i.e., an indicator of urine output and volume). This method was based on the use of tandem affinity/ion-pair HPLC and flow injection analysis. Methods: The free catecholamines were extracted directly from urine by using an on-line phenylboronic acid affinity column. The extracted solutes were then separated and measured by ion-pair chromatography followed by amperometric detection. Creatinine was measured by an on-line flow injection analysis system based on the Jaffe reaction, which analyzed creatinine as it eluted non-retained from the phenylboronic acid column. Results: Various factors were considered in the design and optimization of the phenylboronic acid column, the tandem affinity/ion-pair HPLC columns and the flow injection analysis system. The total analysis time for the final combined system was approximately 16 min per injection at 1 ml/min. This method was found to have good agreement with the expected results for control urine samples. The limits of detection for 20 μl samples (S/N = 3.0) were 1.8, 1.0 and 4.3 μg/l for norepinephrine, epinephrine and dopamine, respectively, while the limit of detection of creatinine was 5.0 mg/l. The linear response of this method extended over a 450 to 930-fold range in concentration for the catecholamines and covered the range of clinical interest. The within-day precision of this method was ± 2.0-2.7%. Conclusions: The ability of this method to simultaneously monitor both creatinine and other analytes makes this HPLC/FIA system an attractive method for use in monitoring urinary compounds. With this approach it was possible to provide fast results for small volumes of random urine samples that were collected as part of a psychological study. The same method could also be utilized with 12 or 24 h urine specimens.

Original languageEnglish (US)
Pages (from-to)63-69
Number of pages7
JournalClinica Chimica Acta
Volume398
Issue number1-2
DOIs
StatePublished - Dec 1 2008

Fingerprint

Flow Injection Analysis
Affinity chromatography
Ion chromatography
Catecholamines
Chromatography
Creatinine
Urine
Ions
Epinephrine
Dopamine
Norepinephrine
High Pressure Liquid Chromatography
Limit of Detection
Monitoring
benzeneboronic acid
Psychology
Injections

Keywords

  • Affinity chromatography
  • Creatinine
  • Flow injection analysis
  • Free catecholamines
  • Ion-pair HPLC
  • Phenylboronic acid

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Determination of free catecholamines in urine by tandem affinity/ion-pair chromatography and flow injection analysis. / Thomas, David H.; Taylor, Jay D.; Barnaby, Omar S.; Hage, David S.

In: Clinica Chimica Acta, Vol. 398, No. 1-2, 01.12.2008, p. 63-69.

Research output: Contribution to journalArticle

@article{dcac01b195b54114857b54de28b7f99c,
title = "Determination of free catecholamines in urine by tandem affinity/ion-pair chromatography and flow injection analysis",
abstract = "Background: A system was developed for the simultaneous measurement in urine of free catecholamines (i.e., dopamine, norepinephrine, epinephrine) and creatinine (i.e., an indicator of urine output and volume). This method was based on the use of tandem affinity/ion-pair HPLC and flow injection analysis. Methods: The free catecholamines were extracted directly from urine by using an on-line phenylboronic acid affinity column. The extracted solutes were then separated and measured by ion-pair chromatography followed by amperometric detection. Creatinine was measured by an on-line flow injection analysis system based on the Jaffe reaction, which analyzed creatinine as it eluted non-retained from the phenylboronic acid column. Results: Various factors were considered in the design and optimization of the phenylboronic acid column, the tandem affinity/ion-pair HPLC columns and the flow injection analysis system. The total analysis time for the final combined system was approximately 16 min per injection at 1 ml/min. This method was found to have good agreement with the expected results for control urine samples. The limits of detection for 20 μl samples (S/N = 3.0) were 1.8, 1.0 and 4.3 μg/l for norepinephrine, epinephrine and dopamine, respectively, while the limit of detection of creatinine was 5.0 mg/l. The linear response of this method extended over a 450 to 930-fold range in concentration for the catecholamines and covered the range of clinical interest. The within-day precision of this method was ± 2.0-2.7{\%}. Conclusions: The ability of this method to simultaneously monitor both creatinine and other analytes makes this HPLC/FIA system an attractive method for use in monitoring urinary compounds. With this approach it was possible to provide fast results for small volumes of random urine samples that were collected as part of a psychological study. The same method could also be utilized with 12 or 24 h urine specimens.",
keywords = "Affinity chromatography, Creatinine, Flow injection analysis, Free catecholamines, Ion-pair HPLC, Phenylboronic acid",
author = "Thomas, {David H.} and Taylor, {Jay D.} and Barnaby, {Omar S.} and Hage, {David S.}",
year = "2008",
month = "12",
day = "1",
doi = "10.1016/j.cca.2008.08.013",
language = "English (US)",
volume = "398",
pages = "63--69",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Determination of free catecholamines in urine by tandem affinity/ion-pair chromatography and flow injection analysis

AU - Thomas, David H.

AU - Taylor, Jay D.

AU - Barnaby, Omar S.

AU - Hage, David S.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Background: A system was developed for the simultaneous measurement in urine of free catecholamines (i.e., dopamine, norepinephrine, epinephrine) and creatinine (i.e., an indicator of urine output and volume). This method was based on the use of tandem affinity/ion-pair HPLC and flow injection analysis. Methods: The free catecholamines were extracted directly from urine by using an on-line phenylboronic acid affinity column. The extracted solutes were then separated and measured by ion-pair chromatography followed by amperometric detection. Creatinine was measured by an on-line flow injection analysis system based on the Jaffe reaction, which analyzed creatinine as it eluted non-retained from the phenylboronic acid column. Results: Various factors were considered in the design and optimization of the phenylboronic acid column, the tandem affinity/ion-pair HPLC columns and the flow injection analysis system. The total analysis time for the final combined system was approximately 16 min per injection at 1 ml/min. This method was found to have good agreement with the expected results for control urine samples. The limits of detection for 20 μl samples (S/N = 3.0) were 1.8, 1.0 and 4.3 μg/l for norepinephrine, epinephrine and dopamine, respectively, while the limit of detection of creatinine was 5.0 mg/l. The linear response of this method extended over a 450 to 930-fold range in concentration for the catecholamines and covered the range of clinical interest. The within-day precision of this method was ± 2.0-2.7%. Conclusions: The ability of this method to simultaneously monitor both creatinine and other analytes makes this HPLC/FIA system an attractive method for use in monitoring urinary compounds. With this approach it was possible to provide fast results for small volumes of random urine samples that were collected as part of a psychological study. The same method could also be utilized with 12 or 24 h urine specimens.

AB - Background: A system was developed for the simultaneous measurement in urine of free catecholamines (i.e., dopamine, norepinephrine, epinephrine) and creatinine (i.e., an indicator of urine output and volume). This method was based on the use of tandem affinity/ion-pair HPLC and flow injection analysis. Methods: The free catecholamines were extracted directly from urine by using an on-line phenylboronic acid affinity column. The extracted solutes were then separated and measured by ion-pair chromatography followed by amperometric detection. Creatinine was measured by an on-line flow injection analysis system based on the Jaffe reaction, which analyzed creatinine as it eluted non-retained from the phenylboronic acid column. Results: Various factors were considered in the design and optimization of the phenylboronic acid column, the tandem affinity/ion-pair HPLC columns and the flow injection analysis system. The total analysis time for the final combined system was approximately 16 min per injection at 1 ml/min. This method was found to have good agreement with the expected results for control urine samples. The limits of detection for 20 μl samples (S/N = 3.0) were 1.8, 1.0 and 4.3 μg/l for norepinephrine, epinephrine and dopamine, respectively, while the limit of detection of creatinine was 5.0 mg/l. The linear response of this method extended over a 450 to 930-fold range in concentration for the catecholamines and covered the range of clinical interest. The within-day precision of this method was ± 2.0-2.7%. Conclusions: The ability of this method to simultaneously monitor both creatinine and other analytes makes this HPLC/FIA system an attractive method for use in monitoring urinary compounds. With this approach it was possible to provide fast results for small volumes of random urine samples that were collected as part of a psychological study. The same method could also be utilized with 12 or 24 h urine specimens.

KW - Affinity chromatography

KW - Creatinine

KW - Flow injection analysis

KW - Free catecholamines

KW - Ion-pair HPLC

KW - Phenylboronic acid

UR - http://www.scopus.com/inward/record.url?scp=54049101463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049101463&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2008.08.013

DO - 10.1016/j.cca.2008.08.013

M3 - Article

C2 - 18773884

AN - SCOPUS:54049101463

VL - 398

SP - 63

EP - 69

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1-2

ER -